Newpath Partners GP IV, LLC

Newpath Partners GP IV, LLC (Boston, MA, USA) — verified investor profile. See contact routes.

About Newpath Partners GP IV, LLC

Newpath Partners IV, LLC is a Boston-based venture capital firm that exclusively invests in life sciences and biotechnology, specializing in a distinctive “company-formation” thesis where it builds biotech companies from the ground up by partnering with leading academic scientists to translate breakthrough biology into therapies. The firm primarily targets Series A stages with substantial check sizes of $50M–$200M+ for leading rounds, while also participating in seed and selective Series B follow-ons. Its portfolio includes 13+ companies focused on gene editing, regenerative medicine, and drug discovery platforms, with notable investments such as Prime Medicine, Chroma Medicine, Metsera, and Autobahn Therapeutics.

Newpath Partners GP IV, LLC at a glance

Also known as
Newpath Partners IV
Location
Boston, MA, USA
Investor type
Venture Capital

Frequently asked about Newpath Partners GP IV, LLC

What does Newpath Partners GP IV, LLC invest in?
We have not verified a stated sector or stage focus for Newpath Partners GP IV, LLC at Newpath Partners IV (Boston, MA, USA). The profile lists the organization, location and investors we track alongside them.
How do I contact Newpath Partners GP IV, LLC?
Newpath Partners GP IV, LLC's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Newpath Partners GP IV, LLC headquartered?
Newpath Partners GP IV, LLC is based in Boston, MA, USA.

StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Boston.

Investors similar to Newpath Partners GP IV, LLC (20)

Browse related investor lists (2)

Compare Newpath Partners GP IV, LLC (8)

Investors like Newpath Partners GP IV, LLC · Full investor directory · Investor access · Company funding database